TRYVIO Trademark

Trademark Overview

On Thursday, November 18, 2021, a trademark application was filed for TRYVIO with the United States Patent and Trademark Office. The USPTO has given the TRYVIO trademark a serial number of 97131670. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by JOHNSON & JOHNSON. The TRYVIO trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
tryvio

General Information

Serial Number97131670
Word MarkTRYVIO
Filing DateThursday, November 18, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
Pseudo MarkTRY VIO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIdorsia Pharmaceuticals Ltd
Party Type21 - New Owner After Publication
Legal Entity Type25 - NOT AVAILABLE
AddressAllschwil CH-4123
CH
Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNEW BRUNSWICK, NJ 08933

Trademark Events

Event DateEvent Description
Monday, November 22, 2021NEW APPLICATION ENTERED
Tuesday, November 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Monday, August 8, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 8, 2022EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 8, 2022EXAMINER'S AMENDMENT ENTERED
Monday, August 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 5, 2023SOU EXTENSION 1 FILED
Friday, May 5, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 2 FILED
Monday, November 6, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 19, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 19, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 20, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, April 11, 2024SOU EXTENSION 3 FILED
Thursday, April 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 22, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 3, 2024SOU EXTENSION 3 GRANTED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 4 FILED
Thursday, October 31, 2024SOU EXTENSION 4 GRANTED
Saturday, May 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tryvio diseases system anti preparations pharmaceutical respiratory oncologic ophthalmic metabolic infectious